Professional Site
While updating my database of human clinical trials using expanded human umbilical cord mesenchymal cells I came across a new article (April, 2016) describing a 36-month safety in subjects given intravenous cells for in a type 2 diabetes study. The … [Continue reading]
Duchenne Muscular Dystrophy (DMD) is a degenerative genetic disorder that affects the muscles in the body in a progressive manner, leading to eventual death. Mesenchymal stem cells (MSC) are able to reach the affected muscle cells and to start tissue … [Continue reading]
Treatment with human umbilical cord mesenchymal stem cells is shown to be effective in controlling hypertension and reducing the infiltration of inflammatory cells in the placenta, in this preeclampsia rat model. Reprod Sci. 2016 Feb 17. … [Continue reading]
Human umbilical cord mesenchymal stem cells (hUCMSC) were found to improve liver condition in rats after acute liver failure, slowing the degeneration of liver cells. The results were comparable whether treatment was administered intravenously or via … [Continue reading]
In this new 2016 study, rats with spinal cord injury (SCI) were treated with conditioned medium or secretome obtained from human CD34 umbilical cord stem cells. Locomotor function was improved; in particular, neurological deficits, cell death, extent … [Continue reading]
Mult Scler Relat Disord. 2015 Mar;4(2):159-69. doi: 10.1016/j.msard.2015.01.005. Epub 2015 Jan 24. High doses of biotin in chronic progressive multiple sclerosis: a pilot study. Sedel F1, Papeix C2, Bellanger A3, Touitou V4, Lebrun-Frenay C5, … [Continue reading]